MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 99 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $48,000 | -9.4% | 743 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $53,000 | -27.4% | 743 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $73,000 | +15.9% | 743 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $63,000 | +6.8% | 743 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $59,000 | -18.1% | 743 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $72,000 | -17.2% | 743 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $87,000 | +4.8% | 743 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $83,000 | -5.7% | 743 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $88,000 | +4.8% | 743 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $84,000 | +68.0% | 743 | 0.0% | 0.01% | +66.7% |
Q1 2020 | $50,000 | -26.5% | 743 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $68,000 | +6.2% | 743 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $64,000 | -17.9% | 743 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $78,000 | -16.1% | 743 | 0.0% | 0.01% | -16.7% |
Q1 2019 | $93,000 | +10.7% | 743 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $84,000 | -57.6% | 743 | -19.7% | 0.01% | -50.0% |
Q3 2018 | $198,000 | +13.1% | 925 | +48.0% | 0.01% | +9.1% |
Q2 2018 | $175,000 | -4.9% | 625 | -68.8% | 0.01% | 0.0% |
Q4 2017 | $184,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |